Yukinori Ozaki
Breast Medical Oncology Cancer Institute Hospital, Japan Foundation for Cancer Research
Dr. Yukinori Ozaki is currently engaged in medical treatment, education, and research specializing in the field of breast cancer. He graduated from Keio University in 2008, worked at Kameda Medical Center from 2010 to 2014, at Toranomon Hospital from 2014 to 2020, and from 2020 at the Cancer Institute Hospital of Japanese Foundation for Cancer Research in Tokyo, which treats the largest number of breast cancer patients in Japan. He is affiliated with the Department of Breast Medical Oncology and the Department of Advanced Medical Development as a head physician. He is interested in clinical trials for breast cancer, especially leading translational research for investigator-initiated clinical trials and immunotherapy. He collaborates with domestic and international clinical trial groups to conduct clinical trials to advance breast cancer care.
Seminars
- MRD detection using ctDNA represents a promising approach for early relapse prediction in breast cancer
- Observational studies showed MRD is a strong prognostic factor consistently across the subtypes and clinical situations
- Interventional MRD-guided trials are now reshaping treatment paradigms
